keliximab
Sign in to saveKeliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
In the Vinony graph
Vinony's link graph records 251 inbound references to keliximab, and connects out to fusion protein, human and monoclonal antibody.
Vinony files it under Chemical pages without DrugBank identifier, Chemicals that do not have a ChemSpider ID assigned and Drugboxes which contain changes to verified fields.
Vinony links it to 5 Wikipedia language editions.
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
== References ==
Excerpted from Wikipedia’s “keliximab” article, available under the CC BY-SA 4.0 licence.